Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 15 of about 15 for Genentech Inc.�
Company Exchange Symbol Last price Quote change Market cap
Biogen Inc NASDAQ BIIB 289.03 +0.68 (0.24%) 63.62B
It also has a collaboration agreement with Genentech, Inc., a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma ...
PDL BioPharma Inc NASDAQ PDLI 3.56 -0.01 (-0.28%) 594.47M
PDL BioPharma, Inc., formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, ...
Genentech, Inc. Private
... human growth hormone Nutropin, cystic fibrosis drug Pulmozyme, and asthma drug Xolair. Genentech is wholly owned by Swiss pharma powerhouse Roche.
Array Biopharma Inc NASDAQ ARRY 3.77 -0.09 (-2.33%) 564.17M
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients ...
Exelixis, Inc. NASDAQ EXEL 8.95 +0.19 (2.17%) 2.08B
Exelixis, Inc. is a biopharmaceutical company. The Company is engaged in developing small molecule therapies for the treatment of cancer.
Roche Holding AG ETR RHO5 106.90 -0.45 (-0.42%) 0.00
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
PDL BIOPHARMA INC. DL-,01 FRA PDL 3.19 +0.01 (0.41%)
BIOGEN INC. DL -,0005 FRA IDP 259.25 -1.59 (-0.61%)
Xenon Pharmaceuticals Inc NASDAQ XENE 7.46 +0.10 (1.36%) 107.02M
(Teva), Genentech, Inc. (Genentech) and Merck & Co., Inc. (Merck). Extreme Genetics discovery platform has yielded the first approved gene therapy product ...
BIOGEN INC. DL -,0005 ETR IDP 259.40 -0.20 (-0.08%)
EXELIXIS INC. DL-,01 FRA EX9 8.01 0.00 (0.00%)
Biogen Idec SWX BIIB 280.50 0.00 (0.00%)
EXELIXIS INC. DL-,01 ETR EX9 0.0000
BIOGEN INC. BMV BIIB 5,360.00 0.00 (0.00%)
BIOGEN DRN BVMF BIIB34 157.25 0.00 (0.00%)